Melexis stock posts 3 percent Q2 sales growth before results

Published on 10/06/2026 at 14:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Melexis stock is priced at EUR 68.50 after Q2 sales rose 3 percent to EUR 217.3 million. Q3 revenue guidance is EUR 220 million to EUR 225 million.

Makrofoto eines integrierten Schaltkreises mit feinen Bonddrähten — Makroaufnahme zeigt winzigen integrierten Schaltkreis mit Goldbonddraehten, passend zu Melexis NV, ISIN BE0165385973, im Sensorchip-Segment, Illustration mit AI erstellt.

Melexis N.V. (ISIN BE0165385973) reported Q2 2026 sales of EUR 217.3 million, up 3 percent from the prior year, while net income fell 19 percent to EUR 30.8 million. The company set Q3 revenue guidance at EUR 220 million to EUR 225 million, giving Melexis stock a clearly defined operating checkpoint before the October results date.

Sales grow while profit contracts

According to Investing.com in its Q2 2026 earnings summary, sales increased 3 percent year over year to EUR 217.3 million in the quarter ended June 30, 2026. Gross margin expanded to 40.5 percent and operating margin reached 17.8 percent, but net income declined to EUR 30.8 million, or EUR 0.76 per share.

The mix matters for investors because the revenue line improved while earnings moved in the opposite direction. Melexis therefore enters the second half with a growth signal in sales but a sharper test for profitability, particularly as automotive demand and inventory patterns remain central to its outlook.

Q3 guidance sets the next test

Investing.com reports that Melexis guided Q3 revenue to EUR 220 million to EUR 225 million after the June quarter. The same summary says the company described China performance as good in Q2 and expected stronger activity in Q3, while robotics was approaching a contribution to revenue.

The next reported checkpoint is October 28, 2026, when Melexis is scheduled to release its next earnings report, according to Investing.com. The EUR 220 million to EUR 225 million range gives the market a concrete measure for judging whether the second-half acceleration is developing as planned.

Analysts see limited upside

The analyst picture is more restrained than the revenue guide. Investing.com lists a Neutral consensus from 13 analysts, including 4 Buy, 7 Hold and 2 Sell ratings. The average 12-month price target is EUR 75.54, with a high estimate of EUR 97.00 and a low estimate of EUR 56.00.

Melexis also continued its capital return program. According to GlobeNewswire on September 21, 2026, the company reported buying 14,519 shares between September 14 and September 18, 2026, at an average price of EUR 64.29. The current program allows purchases of up to 850,000 shares, of which 253,537 had been acquired by that release.

Melexis stock stays below its yearly high

Melexis stock was last at EUR 68.50 on Euronext Brussels on October 5, 2026. Its 52-week range was EUR 48.60 to EUR 86.70, while market capitalization stood at EUR 2.8 billion, leaving the October earnings release as the next quantified test for sales growth and margin conversion.